Expert Rev Clin Immunol. 2013;9(8):735-747. A diet likely to be generally beneficial to IBD patients was developed from [37]. A recipe book was put together, and relevant companies approached for ...

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health Systems, Inc., (Nasdaq: TIVC) today announced it has acquired worldwide exclusive license rights from Statera Biopharma (OTC: STAB) to the late-stage ...

The target for nelitolimod, TLR9, is expressed across cancer types and the mechanical barriers addressed by PEDD are commonly present as well. Nelitolimod delivered by PEDD will be studied across ...